Exercise of Warrants, Issue of Equity and TVR

Iqe

Today 08:21

RNS Number : 4624I
  
IQE PLC
  
16 June 2026
  
 


IQE plc
 
Cardiff, UK
16 June 2026
 
 
Exercise of Warrants, Issue of Equity and TVR
 
IQE plc (AIM:  IQE, "IQE" or the "Group"), the leading global supplier of compound semiconductor wafer products and advanced material solutions, announces that it has received notices of warrant exercise in respect of 5,864,624 ordinary shares of 1 pence each ("Ordinary Shares") in the capital of the Company at an exercise price of 13.5 pence per share.
Admission and Total Voting Rights
Application has been made to the London Stock Exchange for Admission of the 5,864,624 Ordinary Shares to trading on AIM ("Admission"). It is expected that Admission will become effective on or around 17 June 2026.
The Ordinary Shares will be issued fully paid and will rank pari passu in all respects with the Company's existing Ordinary Shares.
Following Admission, the total number of Ordinary Shares in the capital of the Company in issue will be 1,320,656,252 with voting rights. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company's issued share capital.
 
Contacts:
 
IQE plc
+44 (0) 29 2083 9400
Mark Cubitt
Jutta Meier
Amy Barlow
           
Peel Hunt (Nomad and Joint Broker)
+44 (0) 20 7418 8900
Ben Cryer
Kate Bannatyne
Adam Telling
 
Deutsche Numis (Joint Broker)
+44 (0) 20 7260 1000
Simon Willis
Hugo Rubinstein
Iqra Amin
 
Headland Consultancy (Financial PR) 
 + 44 (0) 20 38054822
Andy Rivett-Carnac: +44 (0) 7968 997 365
Chloe Francklin: +44 (0)78 3497 4624
 
ABOUT IQE
http://iqep.com
 
 
IQE is the leading global supplier of advanced compound semiconductor wafers and materials solutions that enable a diverse range of applications across:
 
·    Smart Connected Devices
·    Communications Infrastructure
·    Automotive and Industrial
·    Aerospace and Security
 
As a scaled global epitaxy wafer manufacturer, IQE is uniquely positioned in this market which has high barriers to entry. IQE supplies the global market and is enabling customers to innovate at chip and OEM level. By leveraging the Group's intellectual property portfolio including know-how and patents, it produces epitaxy wafers of superior quality, yield and unit economics.


IQE is headquartered in Cardiff UK, with employees across manufacturing locations in the UK, US and Taiwan, and is listed on the AIM Stock Exchange in London.
 
 




This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
  END
 
 
IOEAKABDOBKKFAD